344 related articles for article (PubMed ID: 3125008)
1. The non-Hodgkin's lymphomas: pathology, staging, treatment.
Hoppe RT
Curr Probl Cancer; 1987; 11(6):363-447. PubMed ID: 3125008
[TBL] [Abstract][Full Text] [Related]
2. Non-Hodgkin's lymphoma.
Smith MR
Curr Probl Cancer; 1996; 20(1):6-77. PubMed ID: 8919170
[TBL] [Abstract][Full Text] [Related]
3. Therapy of non-Hodgkin's lymphoma.
Coffey J; Hodgson DC; Gospodarowicz MK
Eur J Nucl Med Mol Imaging; 2003 Jun; 30 Suppl 1():S28-36. PubMed ID: 12692688
[TBL] [Abstract][Full Text] [Related]
4. Practice guidelines for the management of extranodal non-Hodgkin's lymphomas of adult non-immunodeficient patients. Part I: primary lung and mediastinal lymphomas. A project of the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation.
Zinzani PL; Martelli M; Poletti V; Vitolo U; Gobbi PG; Chisesi T; Barosi G; Ferreri AJ; Marchetti M; Pimpinelli N; Tura S; ; ;
Haematologica; 2008 Sep; 93(9):1364-71. PubMed ID: 18603558
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in the management of non-Hodgkin's lymphomas.
Gaynor ER; Fisher RI
Dis Mon; 1989 Sep; 35(9):597-650. PubMed ID: 2676434
[TBL] [Abstract][Full Text] [Related]
6. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
7. The present status of therapy for patients with aggressive non-Hodgkin's lymphoma.
Vose JM; Armitage JO
Ann Oncol; 1991 Feb; 2 Suppl 2():171-6. PubMed ID: 2049315
[TBL] [Abstract][Full Text] [Related]
8. Current status and future perspectives in the treatment of low-grade non-Hodgkin's lymphomas.
Hiddemann W; Unterhalt M
Blood Rev; 1994 Dec; 8(4):225-33. PubMed ID: 7888829
[TBL] [Abstract][Full Text] [Related]
9. Primary cutaneous non-Hodgkin's lymphoma with aggressive histology: inferior outcome is associated with peripheral T-cell type and elevated lactate dehydrogenase, but not extent of cutaneous involvement.
Visco C; Medeiros LJ; Jones D; Smith T; Rodriguez MA; McLaughlin P; Romaguera J; Cabanillas F; Sarris AH
Ann Oncol; 2002 Aug; 13(8):1290-9. PubMed ID: 12181254
[TBL] [Abstract][Full Text] [Related]
10. Diffuse aggressive lymphomas: a curable subset of non-Hodgkin's lymphomas.
Skarin AT
Semin Oncol; 1986 Dec; 13(4 Suppl 5):10-25. PubMed ID: 2432666
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow involvement by non-Hodgkin's lymphoma: the clinical significance of morphologic discordance between the lymph node and bone marrow. Nebraska Lymphoma Study Group.
Conlan MG; Bast M; Armitage JO; Weisenburger DD
J Clin Oncol; 1990 Jul; 8(7):1163-72. PubMed ID: 1694234
[TBL] [Abstract][Full Text] [Related]
12. Non-Hodgkin's lymphoma of the paranasal sinuses: clinical and pathological features, and response to combined-modality therapy.
Hausdorff J; Davis E; Long G; Hoppe R; van der Pas M; Lassman C; Kamel O; Jacobs C
Cancer J Sci Am; 1997; 3(5):303-11. PubMed ID: 9327155
[TBL] [Abstract][Full Text] [Related]
13. Management of high-grade lymphomas.
Magrath IT
Oncology (Williston Park); 1998 Oct; 12(10 Suppl 8):40-8. PubMed ID: 9830632
[TBL] [Abstract][Full Text] [Related]
14. Treatment of advanced non-Hodgkin's lymphoma in adults.
Friedenberg WR
Wis Med J; 1991 Dec; 90(12):676-8. PubMed ID: 1843059
[TBL] [Abstract][Full Text] [Related]
15. Progress in the management of high risk non-Hodgkin's lymphomas. 10 years of experience of the 3rd Medical Department of Hanusch Hospital, Vienna.
Heinz R; Hanak H; Stacher A
Klin Wochenschr; 1985 Jul; 63(14):619-26. PubMed ID: 3839867
[TBL] [Abstract][Full Text] [Related]
16. T-cell-rich B-cell lymphomas: diagnosis and response to therapy of 44 patients.
Greer JP; Macon WR; Lamar RE; Wolff SN; Stein RS; Flexner JM; Collins RD; Cousar JB
J Clin Oncol; 1995 Jul; 13(7):1742-50. PubMed ID: 7602364
[TBL] [Abstract][Full Text] [Related]
17. The role of radiation therapy in the management of the non-Hodgkin's lymphomas.
Hoppe RT
Cancer; 1985 May; 55(9 Suppl):2176-83. PubMed ID: 2579725
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors for treatment outcome in autotransplantation of intermediate-grade and high-grade non-Hodgkin's lymphoma with cyclophosphamide, carmustine, and etoposide.
Wheeler C; Strawderman M; Ayash L; Churchill WH; Bierer BE; Elias A; Gilliland DG; Antman K; Guinan EC; Eder JP
J Clin Oncol; 1993 Jun; 11(6):1085-91. PubMed ID: 8099120
[TBL] [Abstract][Full Text] [Related]
19. Non-Hodgkin's lymphomas: current classification and management.
Skarin AT; Dorfman DM
CA Cancer J Clin; 1997; 47(6):351-72. PubMed ID: 9371057
[TBL] [Abstract][Full Text] [Related]
20. Therapy for childhood non-Hodgkin's lymphomas, nonlymphoblastic type. Review of recent studies and current recommendations.
Nachman J
Am J Pediatr Hematol Oncol; 1990; 12(3):359-66. PubMed ID: 2240485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
